Indian shares on track for lower open as US-Iran tensions unsettle markets

People walk outside the National Stock Exchange (NSE) in Mumbai, India. (Photo: Reuters)

June 4 (Reuters) – Indian shares are likely to open lower on Thursday, mirroring broader Asian markets, as renewed U.S.-Iran fighting rattled investors globally, even as ​conflicting signs of de-escalation kept them cautious.

GIFT Nifty futures were at ‌23,320, as of 7:23 a.m. IST, indicating the benchmark Nifty 50 would open below its previous close of 23,405.6.

Israel and Lebanon agreed to implement a ceasefire to end ​hostilities, the Trump administration said on Wednesday, boosting hopes for a ​broader deal to end the Iran conflict.

Tehran, which had conditioned ⁠any deal with the U.S. in part on an end to fighting ​between Israel and Lebanon, earlier struck Kuwait, damaging its airport and injuring ​dozens while the U.S. military carried out strikes near the Strait of Hormuz.

Brent crude futures dropped marginally after the Israel-Lebanon ceasefire, but remained elevated around $97 a barrel, while ​Asian shares dropped 1.6%.

India’s benchmark Nifty 50 and Sensex have dropped in ​five of the past six sessions, losing 2.6% and 2.8%, respectively.

Persistent selling by foreign ‌portfolio ⁠investors amid elevated oil prices and uncertainty over India’s position in the global AI landscape have driven the selloff.

FPIs sold Indian shares worth 56.17 billion rupees ($586.91 million) on Wednesday, marking a fourth consecutive session of selling, provisional ​data showed. They ​have offloaded a ⁠record $27.7 billion of shares so far this year.

Investors now await the Reserve Bank of India’s policy decision on ​Friday, where the central bank is expected to keep its ​key rate ⁠steady at 5.25% while signalling a possible hawkish shift due to inflation pressures and weakness in the rupee.

STOCKS TO WATCH

** Bharat Heavy Electricals gets an ⁠international contract ​worth 20 billion-25 billion rupees from Dangote ​Petroleum Refinery & Petrochemicals Free Zone Enterprise, Nigeria.
** Aurobindo Pharma inaugurates a large-scale dedicated biologics contract ​manufacturing facility.

($1 = 95.7050 Indian rupees)